Optiscan CEO Dr. Camile Farah recently joined James Willis on 2GB's Money News program to discuss the Company's journey, technology, and vision for the future of healthcare.
The interview covers Optiscan's history and progress made through 30 years of R&D, the clinical studies currently underway in Australia and the US, and how the Company is working to bring real-time, cellular-level imaging into clinical workflows.
Camile also discusses Optiscan's collaboration with Mayo Clinic, integrating its technology with robotic surgery, the growing role of AI enabled by the Company's digital imaging platform, and why modern healthcare needs to move beyond workflows developed more than a century ago.
It's an insightful discussion on how Optiscan is combining imaging, software and AI to help clinicians make more informed decisions in real time.
